PACB Stock Recent News

PACB LATEST HEADLINES

PACB Stock News Image - seekingalpha.com

Pacific Biosciences of California, Inc. (NASDAQ:PACB ) Q2 2025 Earnings Conference Call August 7, 2025 5:00 PM ET Company Participants Christian O. Henry - President, CEO & Director James R.

seekingalpha.com 2025 Aug 08
PACB Stock News Image - zacks.com

PACB stock jumps after Q2 results beat estimates, with narrow losses, rising margins, and strong global demand.

zacks.com 2025 Aug 08
PACB Stock News Image - fool.com

PACB Sales Up 11%

fool.com 2025 Aug 07
PACB Stock News Image - zacks.com

The headline numbers for Pacific Biosciences (PACB) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

zacks.com 2025 Aug 07
PACB Stock News Image - zacks.com

Pacific Biosciences of California (PACB) came out with a quarterly loss of $0.13 per share versus the Zacks Consensus Estimate of a loss of $0.18. This compares to a loss of $0.2 per share a year ago.

zacks.com 2025 Aug 07
PACB Stock News Image - globenewswire.com

MENLO PARK, Calif., Aug. 06, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced today that management will be participating in the following upcoming investor conferences:

globenewswire.com 2025 Aug 06
PACB Stock News Image - zacks.com

Beyond analysts' top-and-bottom-line estimates for Pacific Biosciences (PACB), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended June 2025.

zacks.com 2025 Aug 04
PACB Stock News Image - globenewswire.com

The most comprehensive, family-based variant dataset ever published will improve variant classification using AI-based tools The most comprehensive, family-based variant dataset ever published will improve variant classification using AI-based tools

globenewswire.com 2025 Aug 04
PACB Stock News Image - zacks.com

Pacific Biosciences of California (PACB) reached $1.54 at the closing of the latest trading day, reflecting a -6.1% change compared to its last close.

zacks.com 2025 Jul 29
PACB Stock News Image - prnewswire.com

New test utilizes technology based on PacBio's PureTarget sequencing method to uncover genetic causes of disease BOSTON , July 29, 2025 /PRNewswire/ -- Athena Diagnostics, the specialty neurology business of Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, today announced a new laboratory test service intended to provide insights into genetic causes of ataxia, a group of progressive, degenerative neurological disorders that affect movement or coordination. The new service is a laboratory developed test that identifies sequences of DNA that repeat many times across a long stretch of the genome.

prnewswire.com 2025 Jul 29
10 of 50